This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Prosthetic Heart Valve Market

Prosthetic Heart Valves: Innovative Solutions for Improving Heart Health and Providing a New Life! Explore More with FMI!

Prosthetic Heart Valve Market by Product, End User & region - Forecast 2022 - 2032

Prosthetic Heart Valve Market Outlook (2022-2032)

[254 Pages Report] The global prosthetic heart valve market size was valued at US$ 10.9 Bn in 2021 and it is likely to touch a valuation of US$ 12.3 Bn by the end of 2022. With rising prevalence of valvular disorders such as aortic stenosis (AS), organic and ischemic (functional) mitral regurgitation, and tricuspid regurgitation, the overall demand for prosthetic valves is projected to grow at a prolific CAGR of 11.4% between 2022 and 2032, totalling US$ 36.3 Bn by 2032.

In terms of end user, the hospitals segment dominated the global prosthetic heart valve market with a total estimated revenue share of over 75% in 2021 and the trend is likely to continue during the forecast period.

Attribute

Key Insights

Prosthetic Heart Valve Market Estimated Value (2022)

US$ 12.3 Bn

Projected Market Value (2032)

US$ 36.3 Bn

Value-based CAGR (2022-2032)

11.4%

Market share of Top 5 countries

62.5%

Prosthetic heart valves are used to replace native heart valves, which poorly function or need to be replaced with an artificial heart for appropriate functioning. The purpose of an artificial valve is to function like a natural heart valve in terms of blood flow in an appropriate path in the body.

Different types of heart valves including mechanical heart valves, biological/tissue valves, and transcatheter heart valves are being used to replace native dysfunctional heart valves.

A mechanical heart valve is an artificial heart valve implanted in a patient suffering from an indicated disease such as aortic stenosis or mitral regurgitation. Tissue heart valves are the biological valves harvested from cow heart sac (bovine) or porcine (pig) heart valves mounted on a stent or used without a stent to replace a dysfunctional heart valve. A transcatheter aortic valve is designed for patients for whom conventional open heart surgery is not a safe option. It is also known as percutaneous aortic valve replacement (PAVR).

Rising cases of valvular heart diseases coupled with increasing number of heart valve replacement procedures performed worldwide is expected to boost the sales of prosthetic heart valves during the forecast period.

Similarly, development and popularity of minimally invasive procedures like transcatheter aortic valve replacement (TAVR) will further accelerate the growth of prosthetic heart valve market over the next decade.

The prosthetic heart valve market formed nearly 1% for the global cardiac assist devices market valued at approx. US$ 1,231 Bn in 2021.

Customize this Report

Let us know your requirement to get
100% FREE customization

Development of Healthcare in the North America to Drive Prosthetic Heart Valve Market

Significant opportunities for new sales exist in developing countries throughout the North American region. As per the 2022 American College of Cardiology Foundation, the prevalence of valvular heart diseases (VHD) is rising in the United States, with more than 5 million Americans diagnosed each year, while up to 1.5 million people suffer from aortic stenosis (AS) in the United States. Approximately 500,000 of these patients suffer from severe AS.

The U.S. accounted for over 85% of the regional revenue share growing over a CAGR of 12.5%. The rise in the prevalence of disorders like diabetes and obesity are major contributing factors to the USA's dominance in this region. Also, the availability of medical expertise, new product launches and government policies are market drivers in the country.

In September 2021, Abbott reported that the United States Food and Drug Administration (USFDA) had approved the company's Epic Plus and Epic Plus Supra Stented Tissue Valves to improve therapy options for people with aortic or mitral valve disease.

Prosthetic Heart Valve Market Download Report Brochure

Key Opportunities for Leading Prosthetic Heart Valve Market Players

The growing prevalence of heart valve disease is a significant factor driving the market's growth. Companies are also aiming to expand their market share by acquiring the local manufacturers.

Major companies in the prosthetic heart valves market comprise Medtronic, Edwards Lifesciences, Boston Scientific Corporation, On-X Life Technologies, Inc., St. Jude Medical, Inc. (Abbott), Cryolife, Inc., Micro Interventional Devices, Inc., Sorin Group, and others.

In January 2022, Artivion, Inc., a leading cardiac and vascular surgery company focused on aortic disease, reported the publication of PROACT clinical trial results in The Annals of Thoracic Surgery, the official journal of the Society of Thoracic Surgeons. The magazine, titled Low-Dose Versus Standard Warfarin After Mechanical Mitral Valve Replacement:

A Randomized Controlled Trial, highlighted outcomes from the multicenter, non-inferiority, a two-arm study that assessed whether, after an On-X mechanical mitral valve replacement (MVR), patients could be safely managed with lower-intensity warfarin plus aspirin. The PROACT Mitral results add to the data from clinical trials that indicate that patients with On-X heart valves can be safely maintained with lower anticoagulation levels than required for competitors' mechanical valves.

Prosthetic heart valves are used to replace native heart valves, which poorly function or need to be replaced with an artificial heart for appropriate functioning. The purpose of an artificial valve is to function like a natural heart in terms of blood flow in an appropriate path in the body. The artificial hearts are implanted in a patient’s body to improve the heart valve functioning.

A mechanical heart valve is an artificial heart valve implanted in a patient suffering from an indicated disease such as aortic stenosis or mitral regurgitation. Tissue heart valves are the biological valves harvested from cow heart sac (bovine) or porcine (pig) heart valves mounted on a stent or used without a stent to replace a dysfunctional heart valve. A transcatheter aortic valve is designed for patients for whom conventional open heart surgery is not a safe option. It is also known as percutaneous aortic valve replacement (PAVR)

Sabyasachi Ghosh
Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

Prosthetic Heart Valve Market Sales Analysis (2014-2021) Vs Demand Outlook (2022-2032)

The global sales of prosthetic heart valves are projected to rise at 11.4% CAGR between 2022 and 2032, in comparison to 11.6% CAGR registered during the historical period (2014-2021), as per Future Market Insights (FMI).

Rising incidence of cardiovascular diseases and valvular heart disorders across the world and advancement in heart valve replacement treatments are some of the key factors driving the global prosthetic heart valve market.

Similarly, growing geriatric population, rising number of cardiac interventions performed worldwide, and increased awareness of the diagnosis and treatment options for heart valve problems are likely to propel the demand for prosthetic heart valves during the forecast period.

With the rapidly evolving lifestyles of the population all over the globe, the number of various diseases and disorders has risen. One of the major disorders that can be caused by the changing lifestyle of people is cardiovascular disease. Unhealthy food, physical inactivity, cigarette consumption, and alcohol consumption are the major behavioural risk factors for heart disease and stroke.

People may experience symptoms, such as high blood pressure, high blood glucose, high blood lipids, overweight, or obesity as a result of behavioural risk factors. These risk factors are detectable in clinics or general healthcare centres and indicate a great risk of stroke, heart attack, malfunctioning of heart valves, heart failure, and other consequences. This will continue to foster the growth of prosthetic heart valve market over the next ten years.

However, high costs of such artificial devices, availability of alternative options for the treatment of heart-related issues/diseases, shortage of healthcare professionals, lack of healthcare infrastructure in lower economies, and strict government guidelines and regulations, are all limiting the growth of the global prosthetic heart valve market.

What are the Key Trends Driving the Prosthetic Heart Valve Market?

  • Advancements in Prosthetic Heart Valves and Popularity of Minimally Invasive Procedures to Boost Market

In recent times, manufacturers have come up with advanced technologies which are effective, long-lasting, less invasive, and improved hemodynamic. These devices are surgically implanted in the body to replace improper/poorly functioning heart valves and come with several benefits. For instance, mechanical heart valves are extremely long-lasting and can function for up to almost 30 years in an appropriate condition.

TAVI (Transcatheter Aortic Valve Implantation), is a recently developed method for the treatment of patients suffering from aortic stenosis. In this treatment, the surgery is performed via the keyhole surgery method without even opening the chest. TAVI comes with the least complications, only 5-10% of patients may require a permanent pacemaker post-surgical treatment.

The survival of mitral valve replacement is high among the geriatric population suffering from valvular heart diseases, which is expected to increase demand for advanced prosthetic mitral valve implantation devices, thus creating lucrative opportunities for players in the market.

MarketNage
Become a MarketNgage Insider

A unified Market Research Subscription Platform, built for today's disparate research needs.

Which are the Factors Restraining Growth in Prosthetic Heart Valve Market?

Low diagnostic screening, poor health awareness across underdeveloped regions, and costly nature of cardiac surgeries are restraining the growth of prosthetic heart valve market.

Similarly, mechanical heart valve failure/malfunction can occur in various cases post-treatment of an artificial heart valve replacement/implantation. Though structural damage is uncommon, infections and blood clots may result in the replacement of some of them. Clots can either open or seal the mechanical valve, causing stenosis, insufficiency, or a combination of the two.

Clots can drift from the artificial valve and dislocate to the arteries and blood vessels that supply/reach the heart (coronary arteries) or the brain (carotid arteries), ultimately, resulting in a stroke or heart attack. Mechanical heart valves have a higher risk of thrombotic or thromboembolic consequences. This is emerging as a key factor expected to limit the growth of prosthetic heart valve market during the projected period.

Country Wise Insights

How Will Growth Unfold in the U.S. Prosthetic Heart Valve Market?

“Increasing Prevalence of Valvular Heart Diseases Driving Market in the U.S.”

As per FMI, the U.S. is expected to account for around 36% share in the global prosthetic heart valve market in 2022 and further expand at 12.5% CAGR during the forecast period. Rising prevalence of disorders like diabetes and obesity, increasing investments in medical research & development, and presence of favourable reimbursement policies are driving the U.S. prosthetic heart valve market.

Over the years, there has been a sharp rise in the number of valvular heart diseases across the U.S. which has necessitated the adoption of cardiac interventions like transcatheter aortic valve replacement (TAVR) and the trend is likely to continue during the forecast period.

According to the Centers for Disease Control and Prevention (CDC), around 2.5% of the U.S. population suffers from valvular heart disease, which is more common in older adults. This will continue to push the demand for prosthetic heart valves in the country during the forecast period.

Moreover, ongoing technological advancements in healthcare sector along with growing popularity of minimally invasive procedures will further generate growth prospects within the prosthetic heart valve market during the forecast period.

What Makes Germany a Prominent Prosthetic Heart Valve Market?

Rising Number of Transcatheter Aortic Valve Replacement Fuelling Sales in Germany”

Germany accounts for around 8.8% revenue share of the global prosthetic heart valve market, making it one of the most lucrative markets across Europe. Increasing incidence of cardiac valve diseases and rising demand for minimally invasive procedures like transcatheter aortic valve replacement (TAVR) are some of the factors driving growth in Germany’s prosthetic heart valve market.

Transcatheter aortic valve replacement (TAVR) has evolved over the years as an alternative, less-invasive option for treating valvular heart diseases. Every year, around 18,000 TAVR per are performed in Germany in 97 centres using about 7 different valve types and with better reimbursement policies. Driven by this, demand for prosthetic heart valves will continue to rise at an impressive pace across the country during the forthcoming decade (2022-2032).

What is the Growth Projection for Japan’s East Asian Prosthetic Heart Valve Market?

“Surge in Geriatric Population Generating Demand in Japan”

The overall prosthetic heart valve market size in Japan reached US$ 634.5 Mn in 2021 and it is expected to grow at a CAGR of 5.8% during the forecast period. Japan faces unprecedented population ageing, and the average life expectancy is longer among the Japanese than the populations around the world. The presence of a geriatric population will boost the demand for prosthetic heart valve products in the country in the coming time as prevalence of heart disease is more among this age group.

Category Wise Insights

Which is the Highly Sought-After Product in the Global Prosthetic Heart Valve Market?

“Demand Remains High for Biological/Tissue Heart Valves in the Market”

Biological/tissue heart valves segment dominated the global prosthetic heart valve with a market share of about 42.1% in 2021 and the trend is likely to continue during the forecast period. This can be attributed to the rising popularity of biological heart valves on account of their less risk of clot formation.

Similarly, growing geriatric population and the advantages of tissue heart valves such as less risk of clot formation and least necessity of anticoagulant treatment are some factors expected to drive the prosthetic heart valves market during the forecast period.

Which is the Leading End User for Prosthetic Heart Valves?

“Most of the Prosthetic Heart Valve Sales to Remain Concentrated in Hospitals”

By end-user, hospitals segment accounted for the highest market share of about 75% in the global prosthetic heart valve market in 2021 and it is likely to retain its dominance during the forecast period.

Availability of advanced machinery, better healthcare setup, presence of trained medical expertise, and growing patient preference for opting for treatments at hospitals are some of the key factors driving growth of this segment.

Competitive Landscape

Major companies in the prosthetic heart valves market comprise Medtronic, Edwards Lifesciences, Boston Scientific Corporation, On-X Life Technologies, Inc., St. Jude Medical, Inc. (Abbott), Cryolife, Inc., Micro Interventional Devices, Inc., Sorin Group, and others.

These leading players are making high investments in the establishment of research institutes in different regions to come up with improvements in their offerings. They are adopting business strategies such as sales contracts, strategic alliances, acquiring technical expertise, new product launches and approvals, joint ventures, partnership agreements, collaborations, digital marketing, mergers and acquisitions, capacity utilisations, technological advancements etc., to gain competitive edge in the global prosthetic heart valve market. For instance,

  • In 2021, Abbott got FDA approval for its Epic Plus and Epic Plus Supra Stended Tissue Valves. This approval will support the treatment of mitral and aortic valve disease.
  • In 2021, Medtronic plc and Spectrum Health announced the partnership agreement to add value in healthcare and improve outcomes for spectrum health patients.

Report Scope as per Prosthetic Heart Valve Industry Analysis

Attribute

Details

Estimated Market Size (2022)

US$ 12.3 Bn

Projected Market Size (2032)

US$ 36.3 Bn

Anticipated Growth Rate (2022-2032)

11.4%

Forecast Period

2022-2032

Historical Data Available for

2014-2021

Market Analysis

US$ Mn for Value

Key Regions Covered

North America, Latin America, Europe, East Asia, South Asia, Oceania and Middle East & Africa (MEA).

Key Countries Covered

USA, Canada, Brazil, Mexico, Argentina, Rest of Latin America, UK, Germany, Italy, Russia, Spain, France, BENELUX, Nordic Countries, Rest of Europe, Japan, China, South Korea, India, Thailand, Indonesia, Malaysia, Vietnam, Philippines, Australia, New Zealand, Turkey, GCC, South Africa, Israel, North Africa and Rest of MEA.

Key Market Segments Covered

Product, End User, Region

Key Companies Profiled

Edward Lifesciences Corporation, St. Jude Medical, Inc., Medtronic plc., Boston Scientific Corporation, Abbott Laboratories, SYMETIS, LivaNova PLC, CryoLife, Inc., Braile Biomedica, Colibri Heart Valve LLC, JenaValve Technology, Inc., Microinterventional Devices, Autotissue Berlin Gmbh, Meril Lifesciences, Comed B.V.

Report Coverage

Market Forecast, Company Share Analysis, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives

Key Market Segments Covered in Prosthetic Heart Valve Industry Research

Product:

  • Mechanical Heart Valves
    • Mechanical Aortic Valve
    • Mechanical Mitral Valve
  • Biological/Tissue Heart Valves
    • Tissue Aortic Valve
    • Tissue Mitral Valve
  • Transcatheter Heart Valves
    • Transcatheter Aortic Valve
    • Transcatheter Mitral Valve

End User:

  • Hospitals
  • Ambulatory Services

Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East and Africa (MEA)

Frequently Asked Questions

The global prosthetic heart valve market is expected to reach about US$ 12.3 Bn in 2022.

As per FMI, the global prosthetic heart valve market is likely to expand at 11.4% CAGR during the forecast period (2022-2032)

The overall prosthetic heart valve market is anticipated to reach a valuation of US$ 36.3 Bn by 2032.

Hospitals segment dominated the global prosthetic heart valve market with a market share of over 75% in 2021.

The U.S., Japan, Canada, and France are the leading countries driving demand for prosthetic heart valves.

Increasing heart-related issues/disorders, advancements in new technologies and less invasive treatments, and growing geriatric population are the major factors driving the global prosthetic heart valve market.

Medtronic Public Limited Company, Edwards Lifesciences Corporation, Boston Scientific Corporation, and St. Jude Medical LLC., are the leading top players in the prosthetic heart valve market.

North America is expected to hold the highest revenue share of about US$ 5.2 Bn in the global prosthetic heart valve market by the end of 2022.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand Side Trends

    1.3. Supply Side Trends

    1.4. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

    2.3. Inclusions and Exclusions

3. Key Market Trends

    3.1. Key Trends Impacting the Market

    3.2. Product Innovation / Development Trends

4. Key Success Factors

    4.1. Disease Epidemiology, by Region

    4.2. Key promotional strategies by manufacturers

    4.3. Regulatory Landscape

    4.4. Value chain analysis

    4.5. Product adoption analysis

    4.6. PESTEL Analysis

    4.7. Porter’s Analysis

5. Market Background

    5.1. Macro-Economic Factors

        5.1.1. Global GDP Growth Outlook

        5.1.2. Global Healthcare Outlook

    5.2. Forecast Factors - Relevance & Impact

        5.2.1. Top Companies Historical Growth

        5.2.2. Increasing Complexity of Healthcare Operations

        5.2.3. Product Pricing

        5.2.4. Product & Stock Availability

        5.2.5. Rising Prevalence of Infections and Surgical Procedures

    5.3. Market Dynamics

        5.3.1. Drivers

        5.3.2. Restraints

        5.3.3. Opportunity Analysis

6. COVID19 Crisis Analysis

    6.1. COVID19 and Impact Analysis

        6.1.1. Revenue By Product

        6.1.2. Revenue By End User

        6.1.3. Revenue By Country

    6.2. 2021 Market Scenario

7. Global Prosthetic Heart Valve Volume (Units) Analysis 2014-2021 and Forecast, 2022-2032

    7.1. Historical Market Volume (Units) Analysis, 2014-2021

    7.2. Current and Future Market Volume (Units) Projections, 2022-2032

        7.2.1. Y-o-Y Growth Trend Analysis

8. Global Prosthetic Heart Valve- Pricing Analysis

    8.1. Regional Pricing Analysis, by Products

    8.2. Pricing Break-up

        8.2.1. Manufacturer Level Pricing

        8.2.2. Distributor Level Pricing

    8.3. Global Average Pricing Analysis Benchmark

    8.4. Pricing Assumptions

9. Global Prosthetic Heart Valve Demand (in Value or Distribution Channel in US$ Mn) Analysis 2014–2021 and Forecast, 2022–2032

    9.1. Historical Market Value (US$ Mn) Analysis, 2014–2021

    9.2. Current and Future Market Value (US$ Mn) Projections, 2022–2032

        9.2.1. Y-o-Y Growth Trend Analysis

        9.2.2. Absolute $ Opportunity Analysis

10. Global Prosthetic Heart Valve Analysis 2014–2021 and Forecast 2022–2032, By Product

    10.1. Introduction / Key Findings

    10.2. Historical Market Size (US$ Mn) Analysis, by Product, 2014–2021

    10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast, by Product, 2022–2032

        10.3.1. Mechanical Heart Valves

            10.3.1.1. Mechanical Aortic Valve

            10.3.1.2. Mechanical Mitral Valve

        10.3.2. Biological/Tissue Heart Valves

            10.3.2.1. Tissue Aortic Valve

            10.3.2.2. Tissue Mitral Valve

        10.3.3. Transcatheter Heart Valves

            10.3.3.1. Transcatheter Aortic Valve

            10.3.3.2. Transcatheter Mitral Valve

    10.4. Market Attractiveness Analysis, by Product

11. Global Prosthetic Heart Valve Analysis 2014–2021 and Forecast 2022–2032, By End User

    11.1. Introduction / Key Findings

    11.2. Historical Market Size (US$ Mn) Analysis, By End User, 2014–2021

    11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast, by End User, 2022–2032

        11.3.1. Hospitals

        11.3.2. Ambulatory Services

    11.4. Market Attractiveness Analysis, by End User

12. Global Prosthetic Heart Valve Analysis 2014–2021 and Forecast 2022–2032, By Region

    12.1. Introduction

    12.2. Historical Market Size (US$ Mn) Analysis, by Region, 2014–2021

    12.3. Current and Future Market Value (US$ Mn) Projections, 2022–2032

        12.3.1. North America

        12.3.2. Latin America

        12.3.3. Europe

        12.3.4. East Asia

        12.3.5. South Asia

        12.3.6. Oceania

        12.3.7. Middle East and Africa (MEA)

    12.4. Market Attractiveness Analysis, by Region

13. North America Prosthetic Heart Valve Analysis 2014–2021 and Forecast 2022–2032

    13.1. Introduction

    13.2. Historical Market Size (US$ Mn) and Volume (Unit) Analysis Trend Analysis, by Market Taxonomy, 2014–2021

    13.3. Current and Future Market Value (US$ Mn) and Volume (Unit) Projections, 2022–2032

        13.3.1. By Country

            13.3.1.1. U.S.

            13.3.1.2. Canada

        13.3.2. By Product

        13.3.3. By End User

    13.4. Market Attractiveness Analysis

        13.4.1. By Country

        13.4.2. By Product

        13.4.3. By End User

    13.5. Market Trends

    13.6. Drivers and Restraints - Impact Analysis

    13.7. Country Level Analysis & Forecast

        13.7.1. U.S. Prosthetic Heart Valve Analysis

            13.7.1.1. Introduction

            13.7.1.2. Market Analysis and Forecast, by Market Taxonomy

                13.7.1.2.1. By Product

                13.7.1.2.2. By End User

        13.7.2. Canada Prosthetic Heart Valve Analysis

            13.7.2.1. Introduction

            13.7.2.2. Market Analysis and Forecast, by Market Taxonomy

                13.7.2.2.1. By Product

                13.7.2.2.2. By End User

14. Latin America Prosthetic Heart Valve Analysis 2014–2021 and Forecast 2022–2032

    14.1. Introduction

    14.2. Historical Market Size (US$ Mn) and Volume (Unit) Analysis Trend Analysis, by Market Taxonomy, 2014–2021

    14.3. Current and Future Market Value (US$ Mn) and Volume (Unit) Projections, 2022–2032

        14.3.1. By Country

            14.3.1.1. Mexico

            14.3.1.2. Brazil

            14.3.1.3. Argentina

            14.3.1.4. Rest of Latin America

        14.3.2. By Product

        14.3.3. By End User

    14.4. Market Attractiveness Analysis

        14.4.1. By Country

        14.4.2. By Product

        14.4.3. By End User

    14.5. Market Trends

    14.6. Drivers and Restraints - Impact Analysis

    14.7. Country Level Analysis & Forecast

        14.7.1. Mexico Prosthetic Heart Valve Analysis

            14.7.1.1. Introduction

            14.7.1.2. Market Analysis and Forecast, by Market Taxonomy

                14.7.1.2.1. By Product

                14.7.1.2.2. By End User

        14.7.2. Brazil Prosthetic Heart Valve Analysis

            14.7.2.1. Introduction

            14.7.2.2. Market Analysis and Forecast, by Market Taxonomy

                14.7.2.2.1. By Product

                14.7.2.2.2. By End User

        14.7.3. Argentina Prosthetic Heart Valve Analysis

            14.7.3.1. Introduction

            14.7.3.2. Market Analysis and Forecast, by Market Taxonomy

                14.7.3.2.1. By Product

                14.7.3.2.2. By End User

15. Europe Prosthetic Heart Valve Analysis 2014–2021 and Forecast 2022–2032

    15.1. Introduction

    15.2. Historical Market Size (US$ Mn) and Volume (Unit) Analysis Trend Analysis, by Market Taxonomy, 2014–2021

    15.3. Current and Future Market Value (US$ Mn) and Volume (Unit) Projections, 2022–2032

        15.3.1. By Country

            15.3.1.1. Germany

            15.3.1.2. Italy

            15.3.1.3. France

            15.3.1.4. U.K.

            15.3.1.5. Spain

            15.3.1.6. BENELUX

            15.3.1.7. Russia

            15.3.1.8. Rest of Europe

        15.3.2. By Product

        15.3.3. By End User

    15.4. Market Attractiveness Analysis

        15.4.1. By Country

        15.4.2. By Product

        15.4.3. By End User

    15.5. Market Trends

    15.6. Drivers and Restraints - Impact Analysis

    15.7. Country Level Analysis & Forecast

        15.7.1. Germany Prosthetic Heart Valve Analysis

            15.7.1.1. Introduction

            15.7.1.2. Market Analysis and Forecast, by Market Taxonomy

                15.7.1.2.1. By Product

                15.7.1.2.2. By End User

        15.7.2. Italy Prosthetic Heart Valve Analysis

            15.7.2.1. Introduction

            15.7.2.2. Market Analysis and Forecast, by Market Taxonomy

                15.7.2.2.1. By Product

                15.7.2.2.2. By End User

                15.7.2.2.3. By Distribution Channel

        15.7.3. France Prosthetic Heart Valve Analysis

            15.7.3.1. Introduction

            15.7.3.2. Market Analysis and Forecast, by Market Taxonomy

                15.7.3.2.1. By Product

                15.7.3.2.2. By End User

        15.7.4. U.K. Prosthetic Heart Valve Analysis

            15.7.4.1. Introduction

            15.7.4.2. Market Analysis and Forecast, by Market Taxonomy

                15.7.4.2.1. By Product

                15.7.4.2.2. By End User

        15.7.5. Spain Prosthetic Heart Valve Analysis

            15.7.5.1. Introduction

            15.7.5.2. Market Analysis and Forecast, by Market Taxonomy

                15.7.5.2.1. By Product

                15.7.5.2.2. By End User

        15.7.6. BENELUX Prosthetic Heart Valve Analysis

            15.7.6.1. Introduction

            15.7.6.2. Market Analysis and Forecast, by Market Taxonomy

                15.7.6.2.1. By Product

                15.7.6.2.2. By End User

        15.7.7. Russia Prosthetic Heart Valve Analysis

            15.7.7.1. Introduction

            15.7.7.2. Market Analysis and Forecast, by Market Taxonomy

                15.7.7.2.1. By Product

                15.7.7.2.2. By End User

16. East Asia Prosthetic Heart Valve Analysis 2014–2021 and Forecast 2022–2032

    16.1. Introduction

    16.2. Historical Market Distribution Channel (US$ Mn) and Volume (Unit) Analysis Trend Analysis, by Market Taxonomy, 2014–2021

    16.3. Current and Future Market Value (US$ Mn) and Volume (Unit) Projections, 2022–2032

        16.3.1. By Country

            16.3.1.1. China

            16.3.1.2. Japan

            16.3.1.3. South Korea

        16.3.2. By Product

        16.3.3. By End User

    16.4. Market Attractiveness Analysis

        16.4.1. By Country

        16.4.2. By Product

        16.4.3. By End User

    16.5. Market Trends

    16.6. Drivers and Restraints - Impact Analysis

    16.7. Country Level Analysis & Forecast

        16.7.1. China Prosthetic Heart Valve Analysis

            16.7.1.1. Introduction

            16.7.1.2. Market Analysis and Forecast, by Market Taxonomy

                16.7.1.2.1. By Product

                16.7.1.2.2. By End User

        16.7.2. Japan Prosthetic Heart Valve Analysis

            16.7.2.1. Introduction

            16.7.2.2. Market Analysis and Forecast, by Market Taxonomy

                16.7.2.2.1. By Product

                16.7.2.2.2. By End User

        16.7.3. South Korea Prosthetic Heart Valve Analysis

            16.7.3.1. Introduction

            16.7.3.2. Market Analysis and Forecast, by Market Taxonomy

                16.7.3.2.1. By Product

                16.7.3.2.2. By End User

17. South Asia Prosthetic Heart Valve Analysis 2014–2021 and Forecast 2022–2032

    17.1. Introduction

    17.2. Historical Market Size (US$ Mn) and Volume (Unit) Analysis Trend Analysis, by Market Taxonomy, 2014–2021

    17.3. Current and Future Market Value (US$ Mn) and Volume (Unit) Projections, 2022–2032

        17.3.1. By Country

            17.3.1.1. India

            17.3.1.2. Indonesia

            17.3.1.3. Malaysia

            17.3.1.4. Thailand

            17.3.1.5. Rest of South Asia

        17.3.2. By Product

        17.3.3. By End User

    17.4. Market Attractiveness Analysis

        17.4.1. By Country

        17.4.2. By Product

        17.4.3. By End User

    17.5. Market Trends

    17.6. Drivers and Restraints - Impact Analysis

    17.7. Country Level Analysis & Forecast

        17.7.1. India Prosthetic Heart Valve Analysis

            17.7.1.1. Introduction

            17.7.1.2. Market Analysis and Forecast, by Market Taxonomy

                17.7.1.2.1. By Product

                17.7.1.2.2. By End User

        17.7.2. Indonesia Prosthetic Heart Valve Analysis

            17.7.2.1. Introduction

            17.7.2.2. Market Analysis and Forecast, by Market Taxonomy

                17.7.2.2.1. By Product

                17.7.2.2.2. By End User

        17.7.3. Malaysia Prosthetic Heart Valve Analysis

            17.7.3.1. Introduction

            17.7.3.2. Market Analysis and Forecast, by Market Taxonomy

                17.7.3.2.1. By Product

                17.7.3.2.2. By End User

        17.7.4. Thailand Prosthetic Heart Valve Analysis

            17.7.4.1. Introduction

            17.7.4.2. Market Analysis and Forecast, by Market Taxonomy

                17.7.4.2.1. By Product

                17.7.4.2.2. By End User

18. Oceania Prosthetic Heart Valve2014-2021 and Forecast 2022-2032

    18.1. Introduction

    18.2. Historical Market Size (US$ Mn) and Volume (Unit) Analysis Trend Analysis, by Market Taxonomy, 2014–2021

    18.3. Current and Future Market Value (US$ Mn) and Volume (Unit) Projections, 2022–2032

        18.3.1. By Country

            18.3.1.1. Australia

            18.3.1.2. New Zealand

        18.3.2. By Product

        18.3.3. By End User

    18.4. Market Attractiveness Analysis

        18.4.1. By Country

        18.4.2. By Product

        18.4.3. By End User

    18.5. Key Market Participants - Intensity Mapping

    18.6. Drivers and Restraints - Impact Analysis

    18.7. Country Level Analysis & Forecast

        18.7.1. Australia Prosthetic Heart Valve Analysis

            18.7.1.1. Introduction

            18.7.1.2. Market Analysis and Forecast, by Market Taxonomy

                18.7.1.2.1. By Product

                18.7.1.2.2. By End User

        18.7.2. New Zealand Prosthetic Heart Valve Analysis

            18.7.2.1. Introduction

            18.7.2.2. Market Analysis and Forecast, by Market Taxonomy

                18.7.2.2.1. By Product

                18.7.2.2.2. By End User

19. Middle East and Africa (MEA) Prosthetic Heart Valve Analysis 2014–2021 and Forecast 2022–2032

    19.1. Introduction

    19.2. Historical Market Size (US$ Mn) and Volume (Unit) Analysis Trend Analysis, by Market Taxonomy, 2014–2021

    19.3. Current and Future Market Value (US$ Mn) and Volume (Unit) Projections, 2022–2032

        19.3.1.  By Country

            19.3.1.1. GCC Countries

            19.3.1.2. Turkey

            19.3.1.3. South Africa

            19.3.1.4. North Africa

            19.3.1.5. Rest of Middle East and Africa

        19.3.2. By Product

        19.3.3. By End User

    19.4. Market Attractiveness Analysis

        19.4.1. By Country

        19.4.2. By Product

        19.4.3. By End User

    19.5. Market Trends

    19.6. Drivers and Restraints - Impact Analysis

    19.7. Country Level Analysis & Forecast

        19.7.1. GCC Countries Prosthetic Heart Valve Analysis

            19.7.1.1. Introduction

            19.7.1.2. Market Analysis and Forecast, by Market Taxonomy

                19.7.1.2.1. By Product

                19.7.1.2.2. By End User

        19.7.2. Turkey Prosthetic Heart Valve Analysis

            19.7.2.1. Introduction

            19.7.2.2. Market Analysis and Forecast, by Market Taxonomy

                19.7.2.2.1. By Product

                19.7.2.2.2. By End User

        19.7.3. South Africa Prosthetic Heart Valve Analysis

            19.7.3.1. Introduction

            19.7.3.2. Market Analysis and Forecast, by Market Taxonomy

                19.7.3.2.1. By Product

                19.7.3.2.2. By End User

        19.7.4. North Africa Safety Needles Market

            19.7.4.1. Introduction

            19.7.4.2. Market Analysis and Forecast, by Market Taxonomy

                19.7.4.2.1. By Product

                19.7.4.2.2. By End User

20. Market Structure Analysis

    20.1. Market Analysis, by Tier of Companies

    20.2. Market Share Analysis of Top Players

    20.3. Market Presence Analysis

21. Competition Analysis

    21.1. Competition Dashboard

    21.2. Competition Benchmarking

    21.3. Competition Deep Dive

        21.3.1. Medtronic Public Health Company

            21.3.1.1. Overview

            21.3.1.2. Product Portfolio

            21.3.1.3. Key Financials

            21.3.1.4. Sales Footprint

            21.3.1.5. Key Financials

            21.3.1.6. SWOT Analysis

            21.3.1.7. Strategy Overview

        21.3.2. Edward Lifesciences Corporation,

            21.3.2.1. Overview

            21.3.2.2. Product Portfolio

            21.3.2.3. Key Financials

            21.3.2.4. Sales Footprint

            21.3.2.5. Key Financials

            21.3.2.6. SWOT Analysis

            21.3.2.7. Strategy Overview

        21.3.3.  St. Jude Medical, Inc.,

            21.3.3.1. Overview

            21.3.3.2. Product Portfolio

            21.3.3.3. Key Financials

            21.3.3.4. Sales Footprint

            21.3.3.5. Key Financials

            21.3.3.6. SWOT Analysis

            21.3.3.7. Strategy Overview

        21.3.4.  Boston Scientific Corporation,

            21.3.4.1. Overview

            21.3.4.2. Product Portfolio

            21.3.4.3. Key Financials

            21.3.4.4. Sales Footprint

            21.3.4.5. Key Financials

            21.3.4.6. SWOT Analysis

            21.3.4.7. Strategy Overview

        21.3.5. Abbott Laboratories,

            21.3.5.1. Overview

            21.3.5.2. Product Portfolio

            21.3.5.3. Key Financials

            21.3.5.4. Sales Footprint

            21.3.5.5. Key Financials

            21.3.5.6. SWOT Analysis

            21.3.5.7. Strategy Overview

        21.3.6.  SYMETIS,

            21.3.6.1. Overview

            21.3.6.2. Product Portfolio

            21.3.6.3. Key Financials

            21.3.6.4. Sales Footprint

            21.3.6.5. Key Financials

            21.3.6.6. SWOT Analysis

            21.3.6.7. Strategy Overview

        21.3.7. LivaNova PLC,

            21.3.7.1. Overview

            21.3.7.2. Product Portfolio

            21.3.7.3. Key Financials

            21.3.7.4. Sales Footprint

            21.3.7.5. Key Financials

            21.3.7.6. SWOT Analysis

            21.3.7.7. Strategy Overview

        21.3.8. CryoLife, Inc.,

            21.3.8.1. Overview

            21.3.8.2. Product Portfolio

            21.3.8.3. Key Financials

            21.3.8.4. Sales Footprint

            21.3.8.5. Key Financials

            21.3.8.6. SWOT Analysis

            21.3.8.7. Strategy Overview

        21.3.9.  Braile Biomedica,

            21.3.9.1. Overview

            21.3.9.2. Product Portfolio

            21.3.9.3. Key Financials

            21.3.9.4. Sales Footprint

            21.3.9.5. Key Financials

            21.3.9.6. SWOT Analysis

            21.3.9.7. Strategy Overview

        21.3.10. Colibri Heart Valve LLC,

            21.3.10.1. Overview

            21.3.10.2. Product Portfolio

            21.3.10.3. Key Financials

            21.3.10.4. Sales Footprint

            21.3.10.5. Key Financials

            21.3.10.6. SWOT Analysis

            21.3.10.7. Strategy Overview

        21.3.11. JenaValve Technology, Inc.,

            21.3.11.1. Overview

            21.3.11.2. Product Portfolio

            21.3.11.3. Key Financials

            21.3.11.4. Sales Footprint

            21.3.11.5. Key Financials

            21.3.11.6. SWOT Analysis

            21.3.11.7. Strategy Overview

        21.3.12. Microinterventional Devices, ;

            21.3.12.1. Overview

            21.3.12.2. Product Portfolio

            21.3.12.3. Key Financials

            21.3.12.4. Sales Footprint

            21.3.12.5. Key Financials

            21.3.12.6. SWOT Analysis

            21.3.12.7. Strategy Overview

        21.3.13. Autotissue Berlin Gmbh,

            21.3.13.1. Overview

            21.3.13.2. Product Portfolio

            21.3.13.3. Key Financials

            21.3.13.4. Sales Footprint

            21.3.13.5. Key Financials

            21.3.13.6. SWOT Analysis

            21.3.13.7. Strategy Overview

        21.3.14. ;Meril Lifesciences,

            21.3.14.1. Overview

            21.3.14.2. Product Portfolio

            21.3.14.3. Key Financials

            21.3.14.4. Sales Footprint

            21.3.14.5. Key Financials

            21.3.14.6. SWOT Analysis

            21.3.14.7. Strategy Overview

        21.3.15. Comed B.V.

            21.3.15.1. Overview

            21.3.15.2. Product Portfolio

            21.3.15.3. Key Financials

            21.3.15.4. Sales Footprint

            21.3.15.5. Key Financials

            21.3.15.6. SWOT Analysis

            21.3.15.7. Strategy Overview

22. Assumptions and Acronyms Used

23. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 01: Global Prosthetic Heart Valve Market Value (US$ Mn) Analysis and Forecast 2014–2032, by Product

Table 02: Global Prosthetic Heart Valve Market Volume (Units) Analysis and Forecast 2014–2032, by Product

Table 03: Global Prosthetic Heart Valve Market Value (US$ Mn) Analysis and Forecast 2014–2032, by End User

Table 04: North America Prosthetic Heart Valve Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022–2032, by Country

Table 05: North America Prosthetic Heart Valve Market Value (US$ Mn) Analysis and Forecast 2014–2032, by Product

Table 06: North America Prosthetic Heart Valve Market Volume (Units) Analysis and Forecast 2014–2032, by Product

Table 07: North America Prosthetic Heart Valve Market Value (US$ Mn) Analysis and Forecast 2014–2032, by End User

Table 08: Latin America Prosthetic Heart Valve Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022–2032, by Country

Table 09: Latin America Prosthetic Heart Valve Market Value (US$ Mn) Analysis and Forecast 2014–2032, by Product

Table 10: Latin America Prosthetic Heart Valve Market Volume (Units) Analysis and Forecast 2014–2032, by Product

Table 11: Latin America Prosthetic Heart Valve Market Value (US$ Mn) Analysis and Forecast 2014–2032, by End User

Table 12: Europe Prosthetic Heart Valve Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022–2032, by Country

Table 13: Europe Prosthetic Heart Valve Market Value (US$ Mn) Analysis and Forecast 2014–2032, by Product

Table 14: Europe Prosthetic Heart Valve Market Volume (Units) Analysis and Forecast 2014–2032, by Product

Table 15: Europe Prosthetic Heart Valve Market Value (US$ Mn) Analysis and Forecast 2014–2032, by End User

Table 16: South Asia Prosthetic Heart Valve Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022–2032, by Country

Table 17: South Asia Prosthetic Heart Valve Market Value (US$ Mn) Analysis and Forecast 2014–2032, by Product

Table 18: South Asia Prosthetic Heart Valve Market Volume (Units) Analysis and Forecast 2014–2032, by Product

Table 19: South Asia Prosthetic Heart Valve Market Value (US$ Mn) Analysis and Forecast 2014–2032, by End User

Table 20: East Asia Prosthetic Heart Valve Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022–2032, by Country

Table 21: East Asia Prosthetic Heart Valve Market Value (US$ Mn) Analysis and Forecast 2014–2032, by Product

Table 22: East Asia Prosthetic Heart Valve Market Volume (Units) Analysis and Forecast 2014–2032, by Product

Table 23: East Asia Prosthetic Heart Valve Market Value (US$ Mn) Analysis and Forecast 2014–2032, by End User

Table 24: Oceania Prosthetic Heart Valve Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022–2032, by Country

Table 25: Oceania Prosthetic Heart Valve Market Value (US$ Mn) Analysis and Forecast 2014–2032, by Product

Table 26: Oceania Prosthetic Heart Valve Market Volume (Units) Analysis and Forecast 2014–2032, by Product

Table 27: Oceania Prosthetic Heart Valve Market Value (US$ Mn) Analysis and Forecast 2014–2032, by End User

Table 28: MEA Prosthetic Heart Valve Market Value (US$ Mn) Analysis 2014-2021 and Forecast 2022–2032, by Country

Table 29: MEA Prosthetic Heart Valve Market Value (US$ Mn) Analysis and Forecast 2014–2032, by Product

Table 30: MEA Prosthetic Heart Valve Market Volume (Units) Analysis and Forecast 2014–2032, by Product

Table 31: MEA Prosthetic Heart Valve Market Value (US$ Mn) Analysis and Forecast 2014–2032, by End User

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

Figure 01: Global Prosthetic Heart Valve Market Volume (Units), 2014 – 2021

Figure 02: Global Prosthetic Heart Valve Market Volume (Units) & Y-o-Y Growth (%) Analysis, 2022–2032

Figure 03: Prosthetic Heart Valve Market, Pricing Analysis per unit (US$), in 2022

Figure 04: Prosthetic Heart Valve Market, Pricing Forecast per unit (US$), in 2032

Figure 05: Global Prosthetic Heart Valve Market Value (US$ Mn) Analysis, 2014–2021

Figure 06: Global Prosthetic Heart Valve Market Forecast & Y-o-Y Growth, 2022–2032

Figure 07: Global Prosthetic Heart Valve Market Absolute $ Opportunity (US$ Mn) Analysis, 2022–2032

Figure 08: Global Prosthetic Heart Valve Market Value Share (%) Analysis 2022 and 2032, by Product

Figure 09: Global Prosthetic Heart Valve Market Y-o-Y Growth (%) Analysis 2022-2032, by Product

Figure 10: Global Prosthetic Heart Valve Market Attractiveness Analysis 2022–2032, by Product

Figure 11: Global Prosthetic Heart Valve Market Value Share (%) Analysis 2022 and 2032, by End User

Figure 12: Global Prosthetic Heart Valve Market Y-o-Y Growth (%) Analysis 2022-2032, by End User

Figure 13: Global Prosthetic Heart Valve Market Attractiveness Analysis 2022–2032, by End User

Figure 14: Global Prosthetic Heart Valve Market Value Share (%) Analysis 2022 and 2032, by Region

Figure 15: Global Prosthetic Heart Valve Market Y-o-Y Growth (%) Analysis 2022-2032, by Region

Figure 16: Global Prosthetic Heart Valve Market Attractiveness Analysis 2022–2032, by Region

Figure 17: North America Prosthetic Heart Valve Market Value (US$ Mn) Analysis, 2014–2021

Figure 18: North America Prosthetic Heart Valve Market Value (US$ Mn) Forecast, 2022-2032

Figure 19: North America Prosthetic Heart Valve Market Value Share, by Product (2022 E)

Figure 20: North America Prosthetic Heart Valve Market Value Share, by End User (2022 E)

Figure 21: North America Prosthetic Heart Valve Market Value Share, by Country (2022 E)

Figure 22: North America Prosthetic Heart Valve Market Attractiveness Analysis by Product, 2022–2032

Figure 23: North America Prosthetic Heart Valve Market Attractiveness Analysis by End User, 2022–2032

Figure 24: North America Prosthetic Heart Valve Market Attractiveness Analysis by Country, 2022–2032

Figure 25: U.S. Prosthetic Heart Valve Market Value Proportion Analysis, 2022

Figure 26: Global Vs. U.S. Growth Comparison, 2021 - 2032

Figure 27: U.S. Prosthetic Heart Valve Market Share Analysis (%) by Product, 2022 & 2032

Figure 28: U.S. Prosthetic Heart Valve Market Share Analysis (%) by End User, 2022 & 2032

Figure 29: Canada Prosthetic Heart Valve Market Value Proportion Analysis, 2022

Figure 30: Global Vs. Canada. Growth Comparison, 2021 - 2032

Figure 31: Canada Prosthetic Heart Valve Market Share Analysis (%) by Product, 2022 & 2032

Figure 32: Canada Prosthetic Heart Valve Market Share Analysis (%) by End User, 2022 & 2032

Figure 33: Latin America Prosthetic Heart Valve Market Value (US$ Mn) Analysis, 2014–2021

Figure 34: Latin America Prosthetic Heart Valve Market Value (US$ Mn) Forecast, 2022-2032

Figure 35: Latin America Prosthetic Heart Valve Market Value Share, by Product (2022 E)

Figure 36: Latin America Prosthetic Heart Valve Market Value Share, by End User (2022 E)

Figure 37: Latin America Prosthetic Heart Valve Market Value Share, by Country (2022 E)

Figure 38: Latin America Prosthetic Heart Valve Market Attractiveness Analysis by Product, 2022–2032

Figure 39: Latin America Prosthetic Heart Valve Market Attractiveness Analysis by End User, 2022–2032

Figure 40: Latin America Prosthetic Heart Valve Market Attractiveness Analysis by Country, 2022–2032

Figure 41: Mexico Prosthetic Heart Valve Market Value Proportion Analysis, 2022

Figure 42: Global Vs Mexico Growth Comparison, 2021 - 2032

Figure 43: Mexico Prosthetic Heart Valve Market Share Analysis (%) by Product, 2022 & 2032

Figure 44: Mexico Prosthetic Heart Valve Market Share Analysis (%) by End User, 2022 & 2032

Figure 45: Brazil Prosthetic Heart Valve Market Value Proportion Analysis, 2022

Figure 46: Global Vs. Brazil. Growth Comparison, 2021 - 2032

Figure 47: Brazil Prosthetic Heart Valve Market Share Analysis (%) by Product, 2022 & 2032

Figure 48: Brazil Prosthetic Heart Valve Market Share Analysis (%) by End User, 2022 & 2032

Figure 49: Argentina Prosthetic Heart Valve Market Value Proportion Analysis, 2022

Figure 50: Global Vs Argentina Growth Comparison, 2021 - 2032

Figure 51: Argentina Prosthetic Heart Valve Market Share Analysis (%) by Product, 2022 & 2032

Figure 52: Argentina Prosthetic Heart Valve Market Share Analysis (%) by End User, 2022 & 2032

Figure 53: Europe Prosthetic Heart Valve Market Value (US$ Mn) Analysis, 2014–2021

Figure 54: Europe Prosthetic Heart Valve Market Value (US$ Mn) Forecast, 2022-2032

Figure 55: Europe Prosthetic Heart Valve Market Value Share, by Product (2022 E)

Figure 56: Europe Prosthetic Heart Valve Market Value Share, by End User (2022 E)

Figure 57: Europe Prosthetic Heart Valve Market Value Share, by Country (2022 E)

Figure 58: Europe Prosthetic Heart Valve Market Attractiveness Analysis by Product, 2022–2032

Figure 59: Europe Prosthetic Heart Valve Market Attractiveness Analysis by End User, 2022–2032

Figure 60: Europe Prosthetic Heart Valve Market Attractiveness Analysis by Country, 2022–2032

Figure 61: UK Prosthetic Heart Valve Market Value Proportion Analysis, 2022

Figure 62: Global Vs. UK Growth Comparison, 2021 - 2032

Figure 63: UK Prosthetic Heart Valve Market Share Analysis (%) by Product, 2022 & 2032

Figure 64: UK Prosthetic Heart Valve Market Share Analysis (%) by End User, 2022 & 2032

Figure 65: Germany Prosthetic Heart Valve Market Value Proportion Analysis, 2022

Figure 66: Global Vs. Germany Growth Comparison, 2021 - 2032

Figure 67: Germany Prosthetic Heart Valve Market Share Analysis (%) by Product, 2022 & 2032

Figure 68: Germany Prosthetic Heart Valve Market Share Analysis (%) by End User, 2022 & 2032

Figure 69: Italy Prosthetic Heart Valve Market Value Proportion Analysis, 2022

Figure 70: Global Vs. Italy Growth Comparison, 2021 - 2032

Figure 71: Italy Prosthetic Heart Valve Market Share Analysis (%) by Product, 2022 & 2032

Figure 72: Italy Prosthetic Heart Valve Market Share Analysis (%) by End User, 2022 & 2032

Figure 73: France Prosthetic Heart Valve Market Value Proportion Analysis, 2022

Figure 74: Global Vs France Growth Comparison, 2021 - 2032

Figure 75: France Prosthetic Heart Valve Market Share Analysis (%) by Product, 2022 & 2032

Figure 76: France Prosthetic Heart Valve Market Share Analysis (%) by End User, 2022 & 2032

Figure 77: Spain Prosthetic Heart Valve Market Value Proportion Analysis, 2022

Figure 78: Global Vs Spain Growth Comparison, 2021 - 2032

Figure 79: Spain Prosthetic Heart Valve Market Share Analysis (%) by Product, 2022 & 2032

Figure 80: Spain Prosthetic Heart Valve Market Share Analysis (%) by End User, 2022 & 2032

Figure 81: Russia Prosthetic Heart Valve Market Value Proportion Analysis, 2022

Figure 82: Global Vs Russia Growth Comparison, 2021 - 2032

Figure 83: Russia Prosthetic Heart Valve Market Share Analysis (%) by Product, 2022 & 2032

Figure 84: Russia Prosthetic Heart Valve Market Share Analysis (%) by End User, 2022 & 2032

Figure 85: BENELUX Prosthetic Heart Valve Market Value Proportion Analysis, 2022

Figure 86: Global Vs BENELUX Growth Comparison, 2021 - 2032

Figure 87: BENELUX Prosthetic Heart Valve Market Share Analysis (%) by Product, 2022 & 2032

Figure 88: BENELUX Prosthetic Heart Valve Market Share Analysis (%) by End User, 2022 & 2032

Figure 89: East Asia Prosthetic Heart Valve Market Value (US$ Mn) Analysis, 2014–2021

Figure 90: East Asia Prosthetic Heart Valve Market Value (US$ Mn) Forecast, 2022-2032

Figure 91: East Asia Prosthetic Heart Valve Market Value Share, by Product (2022 E)

Figure 92: East Asia Prosthetic Heart Valve Market Value Share, by End User (2022 E)

Figure 93: East Asia Prosthetic Heart Valve Market Value Share, by Country (2022 E)

Figure 94: East Asia Prosthetic Heart Valve Market Attractiveness Analysis by Product, 2022–2032

Figure 95: East Asia Prosthetic Heart Valve Market Attractiveness Analysis by End User, 2022–2032

Figure 96: East Asia Prosthetic Heart Valve Market Attractiveness Analysis by Country, 2022–2032

Figure 97: China Prosthetic Heart Valve Market Value Proportion Analysis, 2022

Figure 98: Global Vs. China Growth Comparison, 2021 - 2032

Figure 99: China Prosthetic Heart Valve Market Share Analysis (%) by Product, 2022 & 2032

Figure 100: China Prosthetic Heart Valve Market Share Analysis (%) by End User, 2022 & 2032

Figure 101: Japan Prosthetic Heart Valve Market Value Proportion Analysis, 2022

Figure 102: Global Vs. Japan Growth Comparison, 2021 - 2032

Figure 103: Japan Prosthetic Heart Valve Market Share Analysis (%) by Product, 2022 & 2032

Figure 104: Japan Prosthetic Heart Valve Market Share Analysis (%) by End User, 2022 & 2032

Figure 105: South Korea Prosthetic Heart Valve Market Value Proportion Analysis, 2022

Figure 106: Global Vs South Korea Growth Comparison, 2021 - 2032

Figure 107: South Korea Prosthetic Heart Valve Market Share Analysis (%) by Product, 2022 & 2032

Figure 108: South Korea Prosthetic Heart Valve Market Share Analysis (%) by End User, 2022 & 2032

Figure 109: South Asia Prosthetic Heart Valve Market Value (US$ Mn) Analysis, 2014–2021

Figure 110: South Asia Prosthetic Heart Valve Market Value (US$ Mn) Forecast, 2022-2032

Figure 111: South Asia Prosthetic Heart Valve Market Value Share, by Product (2022 E)

Figure 112: South Asia Prosthetic Heart Valve Market Value Share, by End User (2022 E)

Figure 113: South Asia Prosthetic Heart Valve Market Value Share, by Country (2022 E)

Figure 114: South Asia Prosthetic Heart Valve Market Attractiveness Analysis by Product, 2022–2032

Figure 115: South Asia Prosthetic Heart Valve Market Attractiveness Analysis by End User, 2022–2032

Figure 116: South Asia Prosthetic Heart Valve Market Attractiveness Analysis by Country, 2022–2032

Figure 117: India Prosthetic Heart Valve Market Value Proportion Analysis, 2022

Figure 118: Global Vs. India Growth Comparison, 2021 - 2032

Figure 119: India Prosthetic Heart Valve Market Share Analysis (%) by Product, 2022 & 2032

Figure 120: India Prosthetic Heart Valve Market Share Analysis (%) by End User, 2022 & 2032

Figure 121: Indonesia Prosthetic Heart Valve Market Value Proportion Analysis, 2022

Figure 122: Global Vs. Indonesia Growth Comparison, 2021 - 2032

Figure 123: Indonesia Prosthetic Heart Valve Market Share Analysis (%) by Product, 2022 & 2032

Figure 124: Indonesia Prosthetic Heart Valve Market Share Analysis (%) by End User, 2022 & 2032

Figure 125: Malaysia Prosthetic Heart Valve Market Value Proportion Analysis, 2022

Figure 126: Global Vs. Malaysia Growth Comparison, 2021 - 2032

Figure 127: Malaysia Prosthetic Heart Valve Market Share Analysis (%) by Product, 2022 & 2032

Figure 128: Malaysia Prosthetic Heart Valve Market Share Analysis (%) by End User, 2022 & 2032

Figure 129: Thailand Prosthetic Heart Valve Market Value Proportion Analysis, 2022

Figure 130: Global Vs. Thailand Growth Comparison, 2021 - 2032

Figure 131: Thailand Prosthetic Heart Valve Market Share Analysis (%) by Product, 2022 & 2032

Figure 132: Thailand Prosthetic Heart Valve Market Share Analysis (%) by End User, 2022 & 2032

Figure 133: Oceania Prosthetic Heart Valve Market Value (US$ Mn) Analysis, 2014–2021

Figure 134: Oceania Prosthetic Heart Valve Market Value (US$ Mn) Forecast, 2022-2032

Figure 135: Oceania Prosthetic Heart Valve Market Value Share, by Product (2022 E)

Figure 136: Oceania Prosthetic Heart Valve Market Value Share, by End User (2022 E)

Figure 137: Oceania Prosthetic Heart Valve Market Value Share, by Country (2022 E)

Figure 138: Oceania Prosthetic Heart Valve Market Attractiveness Analysis by Product, 2022–2032

Figure 139: Oceania Prosthetic Heart Valve Market Attractiveness Analysis by End User, 2022–2032

Figure 140: Oceania Prosthetic Heart Valve Market Attractiveness Analysis by Country, 2022–2032

Figure 141: Australia Prosthetic Heart Valve Market Value Proportion Analysis, 2022

Figure 142: Global Vs. Australia Growth Comparison, 2021 - 2032

Figure 143: Australia Prosthetic Heart Valve Market Share Analysis (%) by Product, 2022 & 2032

Figure 144: Australia Prosthetic Heart Valve Market Share Analysis (%) by End User, 2022 & 2032

Figure 145: New Zealand Prosthetic Heart Valve Market Value Proportion Analysis, 2022

Figure 146: Global Vs New Zealand Growth Comparison, 2021 - 2032

Figure 147: New Zealand Prosthetic Heart Valve Market Share Analysis (%) by Product, 2022 & 2032

Figure 148: New Zealand Prosthetic Heart Valve Market Share Analysis (%) by End User, 2022 & 2032

Figure 149: Middle East & Africa Prosthetic Heart Valve Market Value (US$ Mn) Analysis, 2014–2021

Figure 150: Middle East & Africa Prosthetic Heart Valve Market Value (US$ Mn) Forecast, 2022-2032

Figure 151: Middle East & Africa Prosthetic Heart Valve Market Value Share, by Product (2022 E)

Figure 152: Middle East & Africa Prosthetic Heart Valve Market Value Share, by End User (2022 E)

Figure 153: Middle East & Africa Prosthetic Heart Valve Market Value Share, by Country (2022 E)

Figure 154: Middle East & Africa Prosthetic Heart Valve Market Attractiveness Analysis by Product, 2022–2032

Figure 155: Middle East & Africa Prosthetic Heart Valve Market Attractiveness Analysis by End User, 2022–2032

Figure 156: Middle East & Africa Prosthetic Heart Valve Market Attractiveness Analysis by Country, 2022–2032

Figure 157: GCC Countries Prosthetic Heart Valve Market Value Proportion Analysis, 2022

Figure 158: Global Vs GCC Countries Growth Comparison, 2021 - 2032

Figure 159: GCC Countries Prosthetic Heart Valve Market Share Analysis (%) by Product, 2022 & 2032

Figure 160: GCC Countries Prosthetic Heart Valve Market Share Analysis (%) by End User, 2022 & 2032

Figure 161: Turkey Prosthetic Heart Valve Market Value Proportion Analysis, 2022

Figure 162: Global Vs. Turkey Growth Comparison, 2021 - 2032

Figure 163: Turkey Prosthetic Heart Valve Market Share Analysis (%) by Product, 2022 & 2032

Figure 164: Turkey Prosthetic Heart Valve Market Share Analysis (%) by End User, 2022 & 2032

Figure 165: South Africa Prosthetic Heart Valve Market Value Proportion Analysis, 2022

Figure 166: Global Vs. South Africa Growth Comparison, 2021 - 2032

Figure 167: South Africa Prosthetic Heart Valve Market Share Analysis (%) by Product, 2022 & 2032

Figure 168: South Africa Prosthetic Heart Valve Market Share Analysis (%) by End User, 2022 & 2032

Figure 169: North Africa Prosthetic Heart Valve Market Value Proportion Analysis, 2022

Figure 170: Global Vs North Africa Growth Comparison, 2021 - 2032

Figure 171: North Africa Prosthetic Heart Valve Market Share Analysis (%) by Product, 2022 & 2032

Figure 172: North Africa Prosthetic Heart Valve Market Share Analysis (%) by End User, 2022 & 2032

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports

Recommendations

Healthcare

Heart Beat Irregularity Detection Device Market

Published : March 2022

Healthcare

Cardiac Surgery Devices Market

Published : August 2017

Healthcare

Cardiac Rhythm Management Market

Published : February 2022

Healthcare

Cardiac Assist Devices Market

Published : August 2021

Google translate

Prosthetic Heart Valve Market